BIIB - Biogen favored at RBC as Eli Lilly awaits FDA AdCom on Alzheimer's drug
2024-06-05 13:10:12 ET
More on Biogen, Eli Lilly, etc.
- Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript)
- Eli Lilly's Growth And Challenges: A Cautious Buy
- Eli Lilly: Addressing Supply Challenges Should Accelerate Growth
- Alphabet taps Eli Lilly executive as new CFO
- Eli Lilly details NASH effects of weight loss drug